Pfizer seeks authorization for COVID booster shot from US, Europe
Pfizer and partner BioNTech plan to ask US and European regulators within weeks to authorize a booster dose of its COVID-19 vaccine, based on evidence of greater risk of infection six months after inoculation and the spread of the highly contagious Delta variant. The US Food and Drug Administration (FDA) and the Centers for Disease […]
Continue Reading